Keep up to date with news from Gamma Gurus

After 25 years, IBA is still able to offer upgrades on their very first Proton Therapy system allowing Mass General Cancer Center to continue treating patients with the most up-to-date technology.  The ability to upgrade systems in the field is one of IBA's many unique differentiators.   IBA plans total system restoration on its first-ever proton therapy installation | IBA Group (iba-worldwide.com)

We are delighted that Cancer Care Associates have selected C-RAD as their SGRT vendor for their ongoing expansion! https://c-rad.com/press-releases/c-rad-has-been-selected-by-australian-cancer-care-associates-cca-for-their-cancer-clinics-across-australia/

After a well deserved maternity leave, we're so elated to have Nicole Pritchard back on board that we also gave her a promotion!  Nicole is now our Head Radiotherapy Product Guru and will be focussing on key accounts as well as continuing to manage sales of our clinical radiotherapy protfolio. Joining Nicole is Louis Shu who is also a trained Radiation Therapist and has joined us from the Peter MacCallum Cancer Centre.  Louis will be taking over some of Nicole's day-to-day customer interactions and will ensure our high level of customer service is maintained as our product range continues to grow.

Late 2022, CIVCO RT and Qfix announced the merger of their two companies to become a joint manufacturer offering the best of both product ranges - "Better Together".  Gamma Gurus is very pleased to announce that we have been selected to carry both Qfix and CIVCO RT lines in the Australian and New Zealand markets.  We look forward to offering expanded options for our customers such as the innovative Alta™, Access™ & Encompass™ (validated for HyperArc™). Qfix – Gamma Gurus

Gamma Gurus is very pleased to announce the signing of an agency agreement with Bruker BioSpin to market their portfolio of Nuclear Molecular Imaging (NMI) products in Australia & New Zealand. This expands our ability to support the preclinical NMI field by adding additional products, including PET/MR, to the already successful Molecubes range that was acquired by Bruker in November 2021. We look forward to introducing these new products to our customers in 2023!